Saturday, Feb 27, 2021
Focus on the big picture

Valneva Eyes Head-to-Head Vaccine Trial

Bloomberg, 05 Feb 2021
Feb.05 -- Thomas Lingelbach, chief executive officer at Valneva SE, discusses the company's vaccine trials, the difference in processes in working with the U.K. ...
Related Articles